Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C447028 |
2,2',4,6-tetrachlorobiphenyl |
PLA2G6 protein promotes the reaction [2,2',4,6-tetrachlorobiphenyl results in increased secretion of Arachidonic Acid] | increases reaction|increases secretion | 16120751
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PLA2G6 mRNA | affects expression | 21346803
|
C068314 |
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one |
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one results in decreased activity of PLA2G6 protein | decreases activity | 16436530
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PLA2G6 mRNA | affects expression | 16483693
|
D016718 |
Arachidonic Acid |
PLA2G6 protein promotes the reaction [2,2',4,6-tetrachlorobiphenyl results in increased secretion of Arachidonic Acid] | increases reaction|increases secretion | 16120751
|
D001241 |
Aspirin |
Aspirin results in increased expression of PLA2G6 mRNA | increases expression | 11906190
|
D001554 |
Benzene |
Benzene results in decreased expression of PLA2G6 mRNA | decreases expression | 17905399
|
D002118 |
Calcium |
Calcium deficiency results in increased activity of PLA2G6 protein | increases activity | 17885217
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of PLA2G6 mRNA | decreases expression | 18042831
|
C057416 |
KT 5720 |
KT 5720 inhibits the reaction [UCN protein results in decreased expression of PLA2G6 protein] | decreases expression|decreases reaction | 17885217
|
C041786 |
palm oil |
palm oil results in decreased expression of PLA2G6 mRNA | decreases expression | 18042831
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of PLA2G6 mRNA | increases expression | 17681415
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLA2G6 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of PLA2G6 mRNA | increases expression | 19482888
|
D010656 |
Phenylephrine |
PLA2G6 protein affects the susceptibility to Phenylephrine | affects response to substance | 17885217
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PLA2G6 mRNA | increases expression | 20059764 17426115 18301758
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of PLA2G6 mRNA] | increases expression|increases reaction | 20059764
|
C059514 |
resveratrol |
resveratrol results in increased expression of PLA2G6 mRNA | increases expression | 15767336
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of PLA2G6 mRNA | increases expression | 15953391
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PLA2G6 mRNA | decreases expression | 19465110
|
D019284 |
Thapsigargin |
PLA2G6 protein affects the susceptibility to Thapsigargin | affects response to substance | 17885217
|
D019284 |
Thapsigargin |
Thapsigargin results in increased activity of PLA2G6 protein | increases activity | 17885217
|
D019284 |
Thapsigargin |
UCN protein inhibits the reaction [Thapsigargin results in increased activity of PLA2G6 protein] | decreases reaction|increases activity | 17885217
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.09 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.09 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.50 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.79 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.05 | 18653653 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.28 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
16.94 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.94 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.94 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.55 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.89 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.32 | 14761424 11369114 17661222 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.05 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.82 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.46 | 17115116 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.64 | 12372130 20485159 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.23 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
3.03 | 18582451 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.56 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.56 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.72 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.17 | 16183116 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.48 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.22 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
4.35 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
2.34 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
2.34 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.34 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.34 | 17534123 16393696 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.34 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.74 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.60 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.60 | 1701930 20007298 17173139 6705139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.60 | 16227395 19321006 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.53 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.70 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.76 | 15728586 17287366 17124262 11754973 11179087 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.76 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.43 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.72 | 6135515 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.19 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.77 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.06 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
4.15 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
4.15 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
2.94 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.94 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.71 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
2.65 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.65 | 20055451 15322242 10048152 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.95 | 18551238 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.70 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.39 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.71 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.90 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.63 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.63 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.71 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.40 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.94 | 1851702 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
26.29 | 9831321 15177302 9599246 7990266 16716910 11698051 |
MESH:D004487 |
Edema |
|
Aspirin |
26.29 | 17259670 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
26.29 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
26.29 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
26.29 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
26.29 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.85 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.96 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.96 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.78 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.04 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.82 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.86 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.48 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.19 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.96 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
7.50 | 17967931 19551842 18296743 19004024 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.50 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
4.60 | 11852909 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.41 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.41 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
3.91 | 12870263 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
MESH:D006261 |
Headache |
|
Aspirin |
4.90 | 15240983 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.30 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.50 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.59 | 16183116 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
20.18 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
20.18 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
20.18 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
20.18 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.12 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 8697196 15340226 16959395 18606429 16354765 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.71 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.80 | 12083418 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
9.01 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
9.01 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.12 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
9.08 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.08 | 16873680 |
MESH:D006973 |
Hypertension |
|
Benzene |
8.60 | 17940673 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.60 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.60 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.49 | 18502941 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.24 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.58 | 17600658 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
15.54 | 17371808 15177302 9831321 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
15.54 | 20412841 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
15.54 | 12083418 |
MESH:D007249 |
Inflammation |
|
resveratrol |
15.54 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.54 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.49 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.10 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.10 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
2.92 | 16705839 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.99 | 16316344 |
MESH:D007938 |
Leukemia |
|
Benzene |
3.36 | 15935818 14694614 18335105 17119257 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.26 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.69 | 19478238 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.53 | 16087638 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.17 | 8812269 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.54 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.54 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.11 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.11 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.15 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
17.67 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
17.67 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
17.67 | 8742319 15975961 19073162 19482888 19812893 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.67 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
17.67 | 19812893 19073162 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.67 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
13.80 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
13.80 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
13.80 | 2563599 18308698 1399818 17172636 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.80 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.75 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
2.48 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.48 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Benzene |
3.69 | 17119257 17584886 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.24 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.81 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
10.05 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
10.05 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
6.28 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.28 | 8985016 11606380 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.36 | 17992120 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.31 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
4.02 | 15240983 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
7.47 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
7.47 | 14749477 16490592 16267019 17164350 17935668 17049120 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.81 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.44 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
9.43 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.43 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.43 | 16525036 17125593 17188708 17015251 16317513 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.83 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.83 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.89 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.70 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.41 | 17484760 |
MESH:D009325 |
Nausea |
|
Aspirin |
5.16 | 15240983 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.80 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.92 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.94 | 8985016 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.15 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
3.63 | 15643154 |
OMIM:256600 |
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A |
marker/mechanism |
|
| |
OMIM:610217 |
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B |
marker/mechanism |
|
| |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.75 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.34 | 17929310 |
MESH:D009506 |
Nevus |
marker/mechanism |
|
| 19578365 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.89 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.38 | 16723640 21332399 18457598 11836018 20518802 17217161 19632207 20132043 18674790 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.38 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.96 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
8.96 | 16737584 17119257 15576619 15612468 17178637 15727169 15913788 15935809 17479406 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
4.02 | 7009135 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.30 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.74 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.19 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
2.95 | 12562636 |
MESH:D010146 |
Pain |
|
Aspirin |
3.80 | 6995502 6363464 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.47 | 16965848 |
OMIM:612953 |
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE |
marker/mechanism |
|
| |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
5.48 | 11156591 |
MESH:D020795 |
Photophobia |
|
Aspirin |
5.71 | 15240983 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.49 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.56 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
16.00 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
16.00 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.00 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.66 | 17804756 17718901 16731767 17675339 17636462 15767336 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.44 | 12752131 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.53 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.46 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.46 | 16317513 16314181 17520802 17058453 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
4.31 | 12372130 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.77 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.77 | 3137016 11442880 4039156 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.76 | 6407741 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.64 | 7327846 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
5.20 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
5.61 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.61 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
2.42 | 12562636 |
MESH:D020521 |
Stroke |
|
Aspirin |
4.32 | 16403987 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.42 | 16321402 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
4.46 | 17672075 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.89 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.85 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.00 | 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.15 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.26 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.26 | 10091137 |
MESH:D014581 |
Urticaria |
|
Aspirin |
4.38 | 10982225 20485159 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.04 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
9.67 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.67 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.24 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.68 | 16723640 |